Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System
Public ClinicalTrials.gov record NCT03756558. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Cross-SealTM IDE Trial: Prospective, Multi-Center, Single Arm Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System
Study identification
- NCT ID
- NCT03756558
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Terumo Medical Corporation
- Industry
- Enrollment
- 147 participants
Conditions and interventions
Conditions
Interventions
- Cross-Seal System Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 8, 2019
- Primary completion
- Mar 21, 2021
- Completion
- Mar 21, 2021
- Last update posted
- Sep 14, 2025
2019 – 2021
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vascular Institute of the Rockies | Denver | Colorado | 80218 | — |
| River City Clinical Research | Jacksonville | Florida | 32207 | — |
| University of South Florida | Tampa | Florida | 33620 | — |
| University of Iowa Hospital | Iowa City | Iowa | 52242 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Rutgers, The State University of New Jersey | Piscataway | New Jersey | 08854 | — |
| Mt Sinai Medical Center | New York | New York | 10029 | — |
| The Trustees of Columbia University in the City of New York | New York | New York | 10032 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Good Samaritan Hospital | Cincinnati | Ohio | 45220 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| INTEGRIS Cardiovascular Physicians | Oklahoma City | Oklahoma | 73112 | — |
| Lankenau Institute for Medical Research | Wynnewood | Pennsylvania | 19096 | — |
| North Central Heart | Sioux Falls | South Dakota | 57108 | — |
| Holston Valley Medical Center | Kingsport | Tennessee | 37660 | — |
| Cardiothoracic and Vascular Surgeons | Austin | Texas | 78756 | — |
| St. David's Heart and Vascular dba Austin heart | Austin | Texas | 78756 | — |
| Texas Heart Institute and Baylor St. Luke's Medical Center | Houston | Texas | 77030 | — |
| Sentara Medical Group | Norfolk | Virginia | 23502 | — |
| Swedish Medical Center | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03756558, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03756558 live on ClinicalTrials.gov.